Business Headlines 2nd Sep 2015

http://economictimes.indiatimes.com/photo/19555866.cms


2 Sep 2015
Economic Times
Ø   Huge relief for FIIs:Gov not to levy MAT prior to April 1,2015
Ø  Essar controlled LTL, facts misrepresented: CBI
Ø  Govt extends deadline for bids to manage CIL's 10% stake sale
Ø  Sebi seeks public comments to reset clearing corporation norms
Ø  Sept is historically the stock market's worst month
Ø  Govt raises import tariff on gold to $369 per 10 grams
 Business Standard
Ø  US markets more attractive than India's
Ø  China, GDP data spook markets
Ø  Provide subsidy to farmers directly, RBI tells govt
Ø  2015 El Nino is the strongest since 1997-98
Ø  Adani Group wins 50 mw solar power plant in UP
Ø  Fitch Cuts viability rating for PNB, warns IDBI vulnerable to downgrade
Ø  Oil falls 3% on weak China factory data
Business Line
Ø  Fitch affirms ratings on nine Indian banks
Ø  Maruti sales up 9% at 1.06 lakh units in August
Ø  Mahindra & Mahindra sales up 1.29% in August
Ø  L&T wins Rs. 1,070-cr contract in Saudi Arabia
Ø  Western disturbance may stop monsoon-on-retreat
Ø  Oil companies slash Jet fuel price by 11.7% 
 Mint
Ø  Global growth likely to be weaker than expected, says IMF chief
Ø  Banks must move to marginal cost for new base lending rate: RBI
Ø  Global funds eyeing infra assets, betting on govt push for growth
Ø  UltraTech seeks clarification from govt on cement assets deal with Jaypee
Financial Express
Ø  Sensex ends 587 points down at 25,696 on weak GDP data, global cues; Nifty closes at 7,786
Ø  Alstom lowest bidder in Indian Railways locomotives project
Ø   DLF gets shareholders nod to raise up to Rs 7,500 cr
Ø  Jindal Steel shutting down coal mine in Australia
Ø  Bank stocks fall on net interest margins worries
 Financial Chronicle
Ø  Factory output growth slips; all eyes on RBI for rate cut
Ø  Sebi takes actions against unauthoriesed investment schemes
Ø  Consumers in India 'extremely optimistic' about eco prospects: Survey
Ø  Tata group exits Taj Palace Hotel, Dubai
Ø  Sun Pharma completes acquisition of GSK Australia opiates biz

No comments:

Post a Comment